ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Structural Heart Disease Intervention Devices Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-12Q14069
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Structural Heart Disease Intervention Devices Market Research Report 2023
BUY CHAPTERS

Global Structural Heart Disease Intervention Devices Market Research Report 2025

Code: QYRE-Auto-12Q14069
Report
May 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Philips
Neovasc Inc
Transverse Medical
Thubrikar Aortic Valve, Inc.
Boston Scientific
Edwards Lifesciences Corporation
Biomerics
LivaNova
Abbott Structural Heart
Japen Lifeline
Append Medical
Cardiomech

Structural Heart Disease Intervention Devices Market

The global market for Structural Heart Disease Intervention Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Structural heart disease intervention devices are medical devices used to treat heart diseases by repairing or replacing diseased or defective heart tissues or structures through minimally invasive procedures. Common types of structural heart disease intervention devices include:
Atrial septal defect closure devices: used to treat congenital heart defects by inserting a device into the heart through a catheter and placing a closure device over the defect to prevent blood from flowing from the left atrium to the right atrium.
Mitral valve repair devices: used to treat mitral valve regurgitation or prolapse by inserting a device into the heart through a catheter and placing a repair device over the damaged or prolapsed valve.
Transcatheter aortic valve replacement devices: used to treat aortic valve stenosis or regurgitation by inserting an artificial valve into the heart through a catheter and replacing the damaged aortic valve.
Cerebral aneurysm coiling devices: used to treat cerebral aneurysms or narrowing of the blood vessels in the brain by inserting a coil into the blood vessel through a catheter to strengthen the blood vessel and prevent blood from leaking out.
These structural heart disease intervention devices have been widely used in clinical practice and have achieved good treatment results, significantly improving the cardiovascular function of patients and enhancing their quality of life.
North American market for Structural Heart Disease Intervention Devices is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Structural Heart Disease Intervention Devices is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Structural Heart Disease Intervention Devices include Abbott Structural Heart, Philips, Japen Lifeline, Neovasc, Append Medical, Transverse Medical, Cardiomech, Thubrikar Aortic Valve Inc, Boston Scientific, Edwards Lifesciences Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Structural Heart Disease Intervention Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Structural Heart Disease Intervention Devices.
The Structural Heart Disease Intervention Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Structural Heart Disease Intervention Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Structural Heart Disease Intervention Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Structural Heart Disease Intervention Devices Market Report

Report Metric Details
Report Name Structural Heart Disease Intervention Devices Market
Segment by Type
  • Atrial Interventional Class
  • Cardiovascular Intervention
Segment by Application
  • Congenital Heart Disease Treatment
  • Valvular Heart Disease Treatment
  • Cardiomyopathy Treatment
  • Aneurysm and Arterial Valve Disease Treatment
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott Structural Heart, Philips, Japen Lifeline, Neovasc, Append Medical, Transverse Medical, Cardiomech, Thubrikar Aortic Valve Inc, Boston Scientific, Edwards Lifesciences Corporation, Biomerics, LivaNova PLC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Structural Heart Disease Intervention Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Structural Heart Disease Intervention Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Structural Heart Disease Intervention Devices Market report?

Ans: The main players in the Structural Heart Disease Intervention Devices Market are Abbott Structural Heart, Philips, Japen Lifeline, Neovasc, Append Medical, Transverse Medical, Cardiomech, Thubrikar Aortic Valve Inc, Boston Scientific, Edwards Lifesciences Corporation, Biomerics, LivaNova PLC

What are the Application segmentation covered in the Structural Heart Disease Intervention Devices Market report?

Ans: The Applications covered in the Structural Heart Disease Intervention Devices Market report are Congenital Heart Disease Treatment, Valvular Heart Disease Treatment, Cardiomyopathy Treatment, Aneurysm and Arterial Valve Disease Treatment, Others

What are the Type segmentation covered in the Structural Heart Disease Intervention Devices Market report?

Ans: The Types covered in the Structural Heart Disease Intervention Devices Market report are Atrial Interventional Class, Cardiovascular Intervention

1 Structural Heart Disease Intervention Devices Market Overview
1.1 Product Definition
1.2 Structural Heart Disease Intervention Devices by Type
1.2.1 Global Structural Heart Disease Intervention Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 Atrial Interventional Class
1.2.3 Cardiovascular Intervention
1.3 Structural Heart Disease Intervention Devices by Application
1.3.1 Global Structural Heart Disease Intervention Devices Market Value by Application (2024 VS 2031)
1.3.2 Congenital Heart Disease Treatment
1.3.3 Valvular Heart Disease Treatment
1.3.4 Cardiomyopathy Treatment
1.3.5 Aneurysm and Arterial Valve Disease Treatment
1.3.6 Others
1.4 Global Structural Heart Disease Intervention Devices Market Size Estimates and Forecasts
1.4.1 Global Structural Heart Disease Intervention Devices Revenue 2020-2031
1.4.2 Global Structural Heart Disease Intervention Devices Sales 2020-2031
1.4.3 Global Structural Heart Disease Intervention Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Structural Heart Disease Intervention Devices Market Competition by Manufacturers
2.1 Global Structural Heart Disease Intervention Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global Structural Heart Disease Intervention Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Structural Heart Disease Intervention Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Structural Heart Disease Intervention Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Structural Heart Disease Intervention Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Structural Heart Disease Intervention Devices, Product Type & Application
2.7 Global Key Manufacturers of Structural Heart Disease Intervention Devices, Date of Enter into This Industry
2.8 Global Structural Heart Disease Intervention Devices Market Competitive Situation and Trends
2.8.1 Global Structural Heart Disease Intervention Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Structural Heart Disease Intervention Devices Players Market Share by Revenue
2.8.3 Global Structural Heart Disease Intervention Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Structural Heart Disease Intervention Devices Market Scenario by Region
3.1 Global Structural Heart Disease Intervention Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Structural Heart Disease Intervention Devices Sales by Region: 2020-2031
3.2.1 Global Structural Heart Disease Intervention Devices Sales by Region: 2020-2025
3.2.2 Global Structural Heart Disease Intervention Devices Sales by Region: 2026-2031
3.3 Global Structural Heart Disease Intervention Devices Revenue by Region: 2020-2031
3.3.1 Global Structural Heart Disease Intervention Devices Revenue by Region: 2020-2025
3.3.2 Global Structural Heart Disease Intervention Devices Revenue by Region: 2026-2031
3.4 North America Structural Heart Disease Intervention Devices Market Facts & Figures by Country
3.4.1 North America Structural Heart Disease Intervention Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Structural Heart Disease Intervention Devices Sales by Country (2020-2031)
3.4.3 North America Structural Heart Disease Intervention Devices Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Structural Heart Disease Intervention Devices Market Facts & Figures by Country
3.5.1 Europe Structural Heart Disease Intervention Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Structural Heart Disease Intervention Devices Sales by Country (2020-2031)
3.5.3 Europe Structural Heart Disease Intervention Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Structural Heart Disease Intervention Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Structural Heart Disease Intervention Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Structural Heart Disease Intervention Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Structural Heart Disease Intervention Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Structural Heart Disease Intervention Devices Market Facts & Figures by Country
3.7.1 Latin America Structural Heart Disease Intervention Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Structural Heart Disease Intervention Devices Sales by Country (2020-2031)
3.7.3 Latin America Structural Heart Disease Intervention Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Structural Heart Disease Intervention Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Structural Heart Disease Intervention Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Structural Heart Disease Intervention Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Structural Heart Disease Intervention Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Structural Heart Disease Intervention Devices Sales by Type (2020-2031)
4.1.1 Global Structural Heart Disease Intervention Devices Sales by Type (2020-2025)
4.1.2 Global Structural Heart Disease Intervention Devices Sales by Type (2026-2031)
4.1.3 Global Structural Heart Disease Intervention Devices Sales Market Share by Type (2020-2031)
4.2 Global Structural Heart Disease Intervention Devices Revenue by Type (2020-2031)
4.2.1 Global Structural Heart Disease Intervention Devices Revenue by Type (2020-2025)
4.2.2 Global Structural Heart Disease Intervention Devices Revenue by Type (2026-2031)
4.2.3 Global Structural Heart Disease Intervention Devices Revenue Market Share by Type (2020-2031)
4.3 Global Structural Heart Disease Intervention Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Structural Heart Disease Intervention Devices Sales by Application (2020-2031)
5.1.1 Global Structural Heart Disease Intervention Devices Sales by Application (2020-2025)
5.1.2 Global Structural Heart Disease Intervention Devices Sales by Application (2026-2031)
5.1.3 Global Structural Heart Disease Intervention Devices Sales Market Share by Application (2020-2031)
5.2 Global Structural Heart Disease Intervention Devices Revenue by Application (2020-2031)
5.2.1 Global Structural Heart Disease Intervention Devices Revenue by Application (2020-2025)
5.2.2 Global Structural Heart Disease Intervention Devices Revenue by Application (2026-2031)
5.2.3 Global Structural Heart Disease Intervention Devices Revenue Market Share by Application (2020-2031)
5.3 Global Structural Heart Disease Intervention Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott Structural Heart
6.1.1 Abbott Structural Heart Company Information
6.1.2 Abbott Structural Heart Description and Business Overview
6.1.3 Abbott Structural Heart Structural Heart Disease Intervention Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Structural Heart Structural Heart Disease Intervention Devices Product Portfolio
6.1.5 Abbott Structural Heart Recent Developments/Updates
6.2 Philips
6.2.1 Philips Company Information
6.2.2 Philips Description and Business Overview
6.2.3 Philips Structural Heart Disease Intervention Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Philips Structural Heart Disease Intervention Devices Product Portfolio
6.2.5 Philips Recent Developments/Updates
6.3 Japen Lifeline
6.3.1 Japen Lifeline Company Information
6.3.2 Japen Lifeline Description and Business Overview
6.3.3 Japen Lifeline Structural Heart Disease Intervention Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Japen Lifeline Structural Heart Disease Intervention Devices Product Portfolio
6.3.5 Japen Lifeline Recent Developments/Updates
6.4 Neovasc
6.4.1 Neovasc Company Information
6.4.2 Neovasc Description and Business Overview
6.4.3 Neovasc Structural Heart Disease Intervention Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Neovasc Structural Heart Disease Intervention Devices Product Portfolio
6.4.5 Neovasc Recent Developments/Updates
6.5 Append Medical
6.5.1 Append Medical Company Information
6.5.2 Append Medical Description and Business Overview
6.5.3 Append Medical Structural Heart Disease Intervention Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Append Medical Structural Heart Disease Intervention Devices Product Portfolio
6.5.5 Append Medical Recent Developments/Updates
6.6 Transverse Medical
6.6.1 Transverse Medical Company Information
6.6.2 Transverse Medical Description and Business Overview
6.6.3 Transverse Medical Structural Heart Disease Intervention Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Transverse Medical Structural Heart Disease Intervention Devices Product Portfolio
6.6.5 Transverse Medical Recent Developments/Updates
6.7 Cardiomech
6.7.1 Cardiomech Company Information
6.7.2 Cardiomech Description and Business Overview
6.7.3 Cardiomech Structural Heart Disease Intervention Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cardiomech Structural Heart Disease Intervention Devices Product Portfolio
6.7.5 Cardiomech Recent Developments/Updates
6.8 Thubrikar Aortic Valve Inc
6.8.1 Thubrikar Aortic Valve Inc Company Information
6.8.2 Thubrikar Aortic Valve Inc Description and Business Overview
6.8.3 Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Product Portfolio
6.8.5 Thubrikar Aortic Valve Inc Recent Developments/Updates
6.9 Boston Scientific
6.9.1 Boston Scientific Company Information
6.9.2 Boston Scientific Description and Business Overview
6.9.3 Boston Scientific Structural Heart Disease Intervention Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Boston Scientific Structural Heart Disease Intervention Devices Product Portfolio
6.9.5 Boston Scientific Recent Developments/Updates
6.10 Edwards Lifesciences Corporation
6.10.1 Edwards Lifesciences Corporation Company Information
6.10.2 Edwards Lifesciences Corporation Description and Business Overview
6.10.3 Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Product Portfolio
6.10.5 Edwards Lifesciences Corporation Recent Developments/Updates
6.11 Biomerics
6.11.1 Biomerics Company Information
6.11.2 Biomerics Description and Business Overview
6.11.3 Biomerics Structural Heart Disease Intervention Devices Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Biomerics Structural Heart Disease Intervention Devices Product Portfolio
6.11.5 Biomerics Recent Developments/Updates
6.12 LivaNova PLC
6.12.1 LivaNova PLC Company Information
6.12.2 LivaNova PLC Description and Business Overview
6.12.3 LivaNova PLC Structural Heart Disease Intervention Devices Sales, Revenue and Gross Margin (2020-2025)
6.12.4 LivaNova PLC Structural Heart Disease Intervention Devices Product Portfolio
6.12.5 LivaNova PLC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Structural Heart Disease Intervention Devices Industry Chain Analysis
7.2 Structural Heart Disease Intervention Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Structural Heart Disease Intervention Devices Production Mode & Process Analysis
7.4 Structural Heart Disease Intervention Devices Sales and Marketing
7.4.1 Structural Heart Disease Intervention Devices Sales Channels
7.4.2 Structural Heart Disease Intervention Devices Distributors
7.5 Structural Heart Disease Intervention Devices Customer Analysis
8 Structural Heart Disease Intervention Devices Market Dynamics
8.1 Structural Heart Disease Intervention Devices Industry Trends
8.2 Structural Heart Disease Intervention Devices Market Drivers
8.3 Structural Heart Disease Intervention Devices Market Challenges
8.4 Structural Heart Disease Intervention Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Philips
Neovasc Inc
Transverse Medical
Thubrikar Aortic Valve, Inc.
Boston Scientific
Edwards Lifesciences Corporation
Biomerics
LivaNova
Abbott Structural Heart
Japen Lifeline
Append Medical
Cardiomech
List of Tables
 Table 1. Global Structural Heart Disease Intervention Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Structural Heart Disease Intervention Devices Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Structural Heart Disease Intervention Devices Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Structural Heart Disease Intervention Devices Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Structural Heart Disease Intervention Devices Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Structural Heart Disease Intervention Devices Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Structural Heart Disease Intervention Devices Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Structural Heart Disease Intervention Devices Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Structural Heart Disease Intervention Devices, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Structural Heart Disease Intervention Devices, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Structural Heart Disease Intervention Devices, Product Type & Application
 Table 12. Global Key Manufacturers of Structural Heart Disease Intervention Devices, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Structural Heart Disease Intervention Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Structural Heart Disease Intervention Devices as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Structural Heart Disease Intervention Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Structural Heart Disease Intervention Devices Sales by Region (2020-2025) & (K Units)
 Table 18. Global Structural Heart Disease Intervention Devices Sales Market Share by Region (2020-2025)
 Table 19. Global Structural Heart Disease Intervention Devices Sales by Region (2026-2031) & (K Units)
 Table 20. Global Structural Heart Disease Intervention Devices Sales Market Share by Region (2026-2031)
 Table 21. Global Structural Heart Disease Intervention Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Structural Heart Disease Intervention Devices Revenue Market Share by Region (2020-2025)
 Table 23. Global Structural Heart Disease Intervention Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Structural Heart Disease Intervention Devices Revenue Market Share by Region (2026-2031)
 Table 25. North America Structural Heart Disease Intervention Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Structural Heart Disease Intervention Devices Sales by Country (2020-2025) & (K Units)
 Table 27. North America Structural Heart Disease Intervention Devices Sales by Country (2026-2031) & (K Units)
 Table 28. North America Structural Heart Disease Intervention Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Structural Heart Disease Intervention Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Structural Heart Disease Intervention Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Structural Heart Disease Intervention Devices Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Structural Heart Disease Intervention Devices Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Structural Heart Disease Intervention Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Structural Heart Disease Intervention Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Structural Heart Disease Intervention Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Structural Heart Disease Intervention Devices Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Structural Heart Disease Intervention Devices Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Structural Heart Disease Intervention Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Structural Heart Disease Intervention Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Structural Heart Disease Intervention Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Structural Heart Disease Intervention Devices Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Structural Heart Disease Intervention Devices Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Structural Heart Disease Intervention Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Structural Heart Disease Intervention Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Structural Heart Disease Intervention Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Structural Heart Disease Intervention Devices Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Structural Heart Disease Intervention Devices Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Structural Heart Disease Intervention Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Structural Heart Disease Intervention Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Structural Heart Disease Intervention Devices Sales (K Units) by Type (2020-2025)
 Table 51. Global Structural Heart Disease Intervention Devices Sales (K Units) by Type (2026-2031)
 Table 52. Global Structural Heart Disease Intervention Devices Sales Market Share by Type (2020-2025)
 Table 53. Global Structural Heart Disease Intervention Devices Sales Market Share by Type (2026-2031)
 Table 54. Global Structural Heart Disease Intervention Devices Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Structural Heart Disease Intervention Devices Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Structural Heart Disease Intervention Devices Revenue Market Share by Type (2020-2025)
 Table 57. Global Structural Heart Disease Intervention Devices Revenue Market Share by Type (2026-2031)
 Table 58. Global Structural Heart Disease Intervention Devices Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Structural Heart Disease Intervention Devices Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Structural Heart Disease Intervention Devices Sales (K Units) by Application (2020-2025)
 Table 61. Global Structural Heart Disease Intervention Devices Sales (K Units) by Application (2026-2031)
 Table 62. Global Structural Heart Disease Intervention Devices Sales Market Share by Application (2020-2025)
 Table 63. Global Structural Heart Disease Intervention Devices Sales Market Share by Application (2026-2031)
 Table 64. Global Structural Heart Disease Intervention Devices Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Structural Heart Disease Intervention Devices Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Structural Heart Disease Intervention Devices Revenue Market Share by Application (2020-2025)
 Table 67. Global Structural Heart Disease Intervention Devices Revenue Market Share by Application (2026-2031)
 Table 68. Global Structural Heart Disease Intervention Devices Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Structural Heart Disease Intervention Devices Price (US$/Unit) by Application (2026-2031)
 Table 70. Abbott Structural Heart Company Information
 Table 71. Abbott Structural Heart Description and Business Overview
 Table 72. Abbott Structural Heart Structural Heart Disease Intervention Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Structural Heart Structural Heart Disease Intervention Devices Product
 Table 74. Abbott Structural Heart Recent Developments/Updates
 Table 75. Philips Company Information
 Table 76. Philips Description and Business Overview
 Table 77. Philips Structural Heart Disease Intervention Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Philips Structural Heart Disease Intervention Devices Product
 Table 79. Philips Recent Developments/Updates
 Table 80. Japen Lifeline Company Information
 Table 81. Japen Lifeline Description and Business Overview
 Table 82. Japen Lifeline Structural Heart Disease Intervention Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Japen Lifeline Structural Heart Disease Intervention Devices Product
 Table 84. Japen Lifeline Recent Developments/Updates
 Table 85. Neovasc Company Information
 Table 86. Neovasc Description and Business Overview
 Table 87. Neovasc Structural Heart Disease Intervention Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Neovasc Structural Heart Disease Intervention Devices Product
 Table 89. Neovasc Recent Developments/Updates
 Table 90. Append Medical Company Information
 Table 91. Append Medical Description and Business Overview
 Table 92. Append Medical Structural Heart Disease Intervention Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Append Medical Structural Heart Disease Intervention Devices Product
 Table 94. Append Medical Recent Developments/Updates
 Table 95. Transverse Medical Company Information
 Table 96. Transverse Medical Description and Business Overview
 Table 97. Transverse Medical Structural Heart Disease Intervention Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Transverse Medical Structural Heart Disease Intervention Devices Product
 Table 99. Transverse Medical Recent Developments/Updates
 Table 100. Cardiomech Company Information
 Table 101. Cardiomech Description and Business Overview
 Table 102. Cardiomech Structural Heart Disease Intervention Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Cardiomech Structural Heart Disease Intervention Devices Product
 Table 104. Cardiomech Recent Developments/Updates
 Table 105. Thubrikar Aortic Valve Inc Company Information
 Table 106. Thubrikar Aortic Valve Inc Description and Business Overview
 Table 107. Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Product
 Table 109. Thubrikar Aortic Valve Inc Recent Developments/Updates
 Table 110. Boston Scientific Company Information
 Table 111. Boston Scientific Description and Business Overview
 Table 112. Boston Scientific Structural Heart Disease Intervention Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Boston Scientific Structural Heart Disease Intervention Devices Product
 Table 114. Boston Scientific Recent Developments/Updates
 Table 115. Edwards Lifesciences Corporation Company Information
 Table 116. Edwards Lifesciences Corporation Description and Business Overview
 Table 117. Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Product
 Table 119. Edwards Lifesciences Corporation Recent Developments/Updates
 Table 120. Biomerics Company Information
 Table 121. Biomerics Description and Business Overview
 Table 122. Biomerics Structural Heart Disease Intervention Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Biomerics Structural Heart Disease Intervention Devices Product
 Table 124. Biomerics Recent Developments/Updates
 Table 125. LivaNova PLC Company Information
 Table 126. LivaNova PLC Description and Business Overview
 Table 127. LivaNova PLC Structural Heart Disease Intervention Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. LivaNova PLC Structural Heart Disease Intervention Devices Product
 Table 129. LivaNova PLC Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Structural Heart Disease Intervention Devices Distributors List
 Table 133. Structural Heart Disease Intervention Devices Customers List
 Table 134. Structural Heart Disease Intervention Devices Market Trends
 Table 135. Structural Heart Disease Intervention Devices Market Drivers
 Table 136. Structural Heart Disease Intervention Devices Market Challenges
 Table 137. Structural Heart Disease Intervention Devices Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Structural Heart Disease Intervention Devices
 Figure 2. Global Structural Heart Disease Intervention Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Structural Heart Disease Intervention Devices Market Share by Type: 2024 & 2031
 Figure 4. Atrial Interventional Class Product Picture
 Figure 5. Cardiovascular Intervention Product Picture
 Figure 6. Global Structural Heart Disease Intervention Devices Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Structural Heart Disease Intervention Devices Market Share by Application: 2024 & 2031
 Figure 8. Congenital Heart Disease Treatment
 Figure 9. Valvular Heart Disease Treatment
 Figure 10. Cardiomyopathy Treatment
 Figure 11. Aneurysm and Arterial Valve Disease Treatment
 Figure 12. Others
 Figure 13. Global Structural Heart Disease Intervention Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Structural Heart Disease Intervention Devices Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Structural Heart Disease Intervention Devices Sales (2020-2031) & (K Units)
 Figure 16. Global Structural Heart Disease Intervention Devices Average Price (US$/Unit) & (2020-2031)
 Figure 17. Structural Heart Disease Intervention Devices Report Years Considered
 Figure 18. Structural Heart Disease Intervention Devices Sales Share by Manufacturers in 2024
 Figure 19. Global Structural Heart Disease Intervention Devices Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Structural Heart Disease Intervention Devices Players: Market Share by Revenue in Structural Heart Disease Intervention Devices in 2024
 Figure 21. Structural Heart Disease Intervention Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Structural Heart Disease Intervention Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Structural Heart Disease Intervention Devices Sales Market Share by Country (2020-2031)
 Figure 24. North America Structural Heart Disease Intervention Devices Revenue Market Share by Country (2020-2031)
 Figure 25. United States Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Structural Heart Disease Intervention Devices Sales Market Share by Country (2020-2031)
 Figure 28. Europe Structural Heart Disease Intervention Devices Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Structural Heart Disease Intervention Devices Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Structural Heart Disease Intervention Devices Revenue Market Share by Region (2020-2031)
 Figure 36. China Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Structural Heart Disease Intervention Devices Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Structural Heart Disease Intervention Devices Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Structural Heart Disease Intervention Devices Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Structural Heart Disease Intervention Devices Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Structural Heart Disease Intervention Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Structural Heart Disease Intervention Devices by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Structural Heart Disease Intervention Devices by Type (2020-2031)
 Figure 55. Global Structural Heart Disease Intervention Devices Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Structural Heart Disease Intervention Devices by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Structural Heart Disease Intervention Devices by Application (2020-2031)
 Figure 58. Global Structural Heart Disease Intervention Devices Price (US$/Unit) by Application (2020-2031)
 Figure 59. Structural Heart Disease Intervention Devices Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Structural Heart Disease Treatment Devices Market Research Report 2024
Interventional Devices for Structural Heart Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transcatheter Structural Heart Device Market Research Report 2024
Global Structural Heart Devices Market Insights Forecast to 2030
Global Structural Heart Diseases Device Market Research Report 2025
Global Cardiac Interventional Device Market Research Report 2024
Global Cardiovascular Interventional Devices Market Research Report 2025
Global Heart Valve Interventional Equipment Market Research Report 2024
Global Surgical Structural Heart Device Market Research Report 2025
Structural Cardiac Implants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cardiovascular Interventional Product Market Research Report 2025
Global Diagnostic Interventional Cardiology Devices Market Insights Forecast to 2030
Global Interventional Device Market Research Report 2024
Structural Heart Imaging SHI Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Interventional Coronary Catheters Market Research Report 2024
Global Heart Valve Repair and Replacement Devices Market Research Report 2024
Global Diagnostic Interventional Cardiology Instruments Market Insights Forecast to 2030
Global Vascular Intervention Medical Devices Market Research Report 2025
Interventional Heart Valve Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Interventional Ventricular Assist Devices Market Research Report 2024

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions